Stay updated with breaking news from Forbeswill Ozempic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The surging popularity of weight-loss drugs may immediately seem to be potentially problematic for fitness stocks, as individuals have an alternative to shed pounds, b...
Revenue for the Danish company behind the booming GLP-1 injectable drugs is up 29% so far this year.
Analysts say the impact of Ozempic and peers’ boom in popularity is “real” and “not small” on the food and beverage industry as a whole.